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Abstract. Background: Although brain tumors only 1.4% of all tumors, high fatality rate 
made these tumors need special attention. In North Sumatera, there is no data on brain tumors 
patients profile. Objective: To determine brain tumor patients’ profile in North Sumatera, 
Indonesia. Method: A descriptive hospital-based study with primary data which taken from 
September–December 2012. Result: Of 75 brain tumors patients surveyed in 10 hospitals in 
North Sumatera 38 (50.7%) patients were male and 37 (49.3%) patients were female. Mean 
of age was 51.45 (11–87) years old. Most of the subjects were housewifes, 26 (34.7%) 
patients. The most common cause that brought these patients to see doctors was headache 32 
(42.7%), followed by decreased level of consciousness 17 (22.7%). Clinical manifestations 
found in these patients were headache 67 (89.3%), dizziness/vertigo 41 (54.7%), convulsion 
22 (29.3%), vomitting 32 (42.7%), motor dysfunction 46 (61.3%), sensory dysfunction 21 
(28%), and cognitive decline 21 (28%). Only 7 patients (9.3%) had history of tumor in his/her 
relatives. Eighteen patients (24%) were treated surgically and 8 (10.7%) were given 
radiotherapy. 71 patients were alive (94.7%) when discharged from the hospitals due to 
various reasons. Head CT Scan/MRI showed primary tumors in 56 (74.7%) patients. Of these 
primary tumors 25 (44.6%) patients were meningioma and 19 (33.9%) were astrocytoma. Of 
19 (25.3%) patients with secondary tumor, most common primary tumor where found in the 
lung 11 (57.9%). Conclusion: Sex the patients were equally distributed with mean of age 
was 51.45 (11–87) years old. The most common cause that brought these patients to seek for 
treatment were headache. Most of these patients were treated conservatively. The most 
common head CT Scan/MRI findings showed primary tumors. 
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1. Introduction 
The Brain tumors covered only 1.4% of all malignancy, however high fatality rate and traumatic 
experience was unavoidable for patients and family members made these brain tumors need a 
particular attention[1]. The treatment of patients with tumors was different from another 
malignancy [2]. 
In adults, secondary tumors are ten times more common than primary tumors, whereas the 
incidence of primary tumors reached 14.4 / 100,000 population with glioma as the most frequent 
types (40%) [1–3]. 
Histopathologically, tumors were classified into: neuroepithelial tissue tumors (gliomas, 
including astrocytoma, anaplastic astrocytes, glioblastoma, oligodendroglioma, and 
ependimoma), meningeal tumor (meningioma and hemangioblastoma), germ cell tumors, and 
sellar tumors (pituitary tumors and craniofaringiomas) [4]. 
2. Methodology 
This study was a descriptive study with the cross-sectional method of brain tumor patients who 
were treated at 10 hospitals in North Sumatra Province. Data collection was conducted from 
September-December 2012 by neurologists who served in the hospitals of this study. 
The data analysis was done by using data processing software and Statistical Package for Social 
Sciences (SPSS). 
3. Results and Discussion 
Description The data collection was collected on brain tumor patients were treated at 10 hospitals 
in North Sumatra, obtained a total of 75 research subjects for descriptive study. This study showed 
38 (50.7%) male patients and 37 (49.3%) female patients. Male patients with brain tumors 
(60.74%) are more than female patients (39.26%) [4,5]. The mean age in this study was 51.45 
(11-87) years. In the United States, the mean age at diagnosis in patients with primary tumors is 
57 years [4].Although tumors can occurs at any age, however it is more common in late middle 
age [6]. 
Most of subject occupations for this study were housewives 26 (34.7%). Table distribution of 
subjects' medical condition (Table 2) showed the most commons chief complaints were: headache 
32 (42.7%), followed by decreased level consciousness 17 (22.7%), hemiparesis 12 (16%), and 
seizures 11 (14.7%). Clinical manifestations were experienced by patients: headache 67 (89.3%), 
dizziness / vertigo 41 (54.7%), seizures 22 (29.3%), vomiting 32 (42.7%), motor disorders 46 
(61.3%), sensory disturbances 21 (28%), Cognitive decline 21 (28%), and decreasing level 
consciousness 17 (22.7%). Headache is the first symptom found in approximately 30-40% of 
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brain tumor patients [4,6]. Seizures occur in 33% of patients with brain tumors [6]. Seizure is the 
earliest symptom of brain tumors in 25% of cases and more than 35% of cases at an advanced 
stage [4]. Vomiting was found in 30% of cases and commonly accompanies with headache [4]. 
Patients who had a family history of brain tumors were only 7 (9.3%). Patients were treated 
surgically 18 (24%) and were given radiotherapy 8 (10.7%), 71 patients were alive (94.7%) at the 
end of data collection. 
Based on the CT Scan/MRI head: primary tumors were 56 patients (74.7%), secondary tumors 
were 19 patients (25.3%). On the secondary tumors, most metastases from the lung 11 (57.9%) 
cases, while the primary tumor: meningioma 25 (44.6%) and astrocytoma 19 (33.9%). Based on 
the Fisher's research, et al. it was found that Primary brain tumors (80%) and secondary (20%). 4 
Brain metastases was found in 20-40% of cancer patients and have 10:1 ratio with a primary brain 
tumors [7,8]. The typed of cancer most commonly metastasizes to the brain is lung cancer, is 30-
60% of brain metastases [7,8]. In the US 35,000 new cases of brain tumors was found each year, 
the most common tumor type is meningioma (39.26%) [4]. In Japanese studies, 32% of the 
primary brain tumors was meningioma [6]. Astrocytoma was about 35% of primary brain tumors 
[5,6]. 
The limitation of this study is neuroimaging scans done by different tools and interpreted by 
different radiologists, so that the accuracy of diagnostic in radiology was vary, the diagnosis 
definitely cannot do biopsy and the accurate result could not be obtained because the patient was 
not followed by the treatment of the disease after getting out from the hospital. 
 
Table 1. Characteristic Demographic Distribution of Research Study  
Demographic 
Characteristic 
Total Percentage 
Sex   
Male 38 50.7 
Female  37 49.3 
Occupation 26  
Housewife 26 34.7 
Private 17 22.7 
Jobless 13 17.3 
Etc. 8 10.7 
Pensiunan 6 8.0 
Public civil servant 5 6.7 
 
Table 2. Clinical Condition Distribution of Research Study 
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Clinical condition Total Percentage 
Main Complaint   
Headache 32 42.7 
Decresing level of consciousness 17 22.7 
Convulsion 12 16.0 
Hemiparesis 11 14.7 
Visual dysfunction 2 2.6 
Vertigo 1 1.3 
Consciousness   
Conscious 58 77.3 
Decreasing level of 
consciousness 
17 22.7 
Headache   
Yes 67 89.3 
No 8 10.7 
Dizziness/vertigo   
Yes 41 54.7 
No 34 45.3 
Convulsion   
Yes 22 29.3 
No 53 70.7 
Vomiting   
Yes 32 42.7 
No 43 57.3 
Motor dysfunction   
Yes 46 61.3 
No 29 38.7 
Sensory dysfunction   
Yes 21 28.0 
No 54 72.0 
Congitive dysfunction   
Yes 7 28.0 
No 68 72.0 
Family background   
Yes 18 9.3 
No 57 90.7 
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Operation   
Yes 8 24.0 
No 67 76.0 
Radiotherapy   
Yes 8 10.7 
No 
OutCome 
67 89.3 
Alive 71 94.7 
Dead 4 5.3 
Result CT Scan/MRI   
Primer 56 74.7 
Metastasis 19 25.3 
 
4. Conclusion 
This is amounts of male patients was compatible with female patients. The mean age was 51.45 
(11-87) years. The most frequent main complaint was headache. During the first checked, most 
of the patients were conscious. Most of the patients got conservatives therapy and the result was 
alive at the time the patient got out of the hospital with various reasons. Based on CT Scan/MRI 
head result, most of them showed the imagining of primary tumor (Meningioma and astrocytoma). 
The certain diagnosis was not obtained because biopsy was not performed. 
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